High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage

Therapy Options ◽

Intravesical Bcg ◽

Upper urinary tract surveillance in patients with high risk non-muscle invasive bladder cancer managed with intravesical BCG

European Urology Open Science ◽

10.1016/s2666-1683(20)36267-4 ◽

2020 ◽

Vol 21 ◽

pp. S234

Author(s):

H. Baig ◽

G.M. Nandwani

Keyword(s):

Bladder Cancer ◽

Urinary Tract ◽

High Risk ◽

Upper Urinary Tract ◽

Invasive Bladder Cancer ◽

Intravesical Bcg ◽

Is intravesical BCG alone still the only truly effective intravesical therapy for high risk non-muscle invasive bladder cancer?

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e15544 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e15544-e15544

Author(s):

Savino Mauro Di Stasi ◽

Claus Riedl ◽

Cristian Verri ◽

Francesco Celestino ◽

Francesco De Carlo ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Invasive Bladder Cancer ◽

Intravesical Therapy ◽

Intravesical Bcg ◽

COVID‐19 infection threat in patients with high‐risk non‐muscle invasive bladder cancer receiving intravesical BCG therapy

International Journal of Clinical Practice ◽

10.1111/ijcp.13752 ◽

2020 ◽

Author(s):

Serkan Akan ◽

Caner Ediz ◽

Yunus Emre Kızılkan ◽

Adem Alcin ◽

Hasan Huseyin Tavukcu ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Invasive Bladder Cancer ◽

Bcg Therapy ◽

Intravesical Bcg ◽

Muscle Invasive ◽

Intravesical Bcg Therapy

Is Electromotive Mitomycin C an Alternative Treatment for Frail Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Failed Intravesical BCG?

British Journal of Medical and Surgical Urology ◽

10.1016/j.bjmsu.2009.09.003 ◽

2009 ◽

Vol 2 (6) ◽

pp. 252-252

Author(s):

B.E. Ayres ◽

B.S.I. Montgomery ◽

T. Parker ◽

J. Borwell ◽

N.J. Barber

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Alternative Treatment ◽

Invasive Bladder Cancer ◽

Frail Patients ◽

Intravesical Bcg ◽

Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer – is there a long-term survival difference? A Swedish nationwide analysis

Scandinavian Journal of Urology ◽

10.1080/21681805.2020.1851763 ◽

2020 ◽

pp. 1-7

Author(s):

Eugen Y-H Wang ◽

Ulf Larsson ◽

Truls Gårdmark ◽

Per-Uno Malmström

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Radical Cystectomy ◽

Invasive Bladder Cancer ◽

Term Survival ◽

Survival Difference ◽

Intravesical Bcg ◽

Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-020-03453-x ◽

2020 ◽

Author(s):

Bin Huang ◽

Gaowei Huang ◽

Wenji Li ◽

Lingwu Chen ◽

Xiaopeng Mao ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Transurethral Resection ◽

Bladder Tumor ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Bcg Immunotherapy ◽

Intravesical Bcg ◽

Re: Radical Cystectomy (Bladder Removal) Against Intravesical BCG Immunotherapy for High-risk Non-muscle Invasive Bladder Cancer (BRAVO): A Protocol for a Randomised Controlled Feasibility Study

European Urology ◽

10.1016/j.eururo.2017.12.007 ◽

2018 ◽

Vol 73 (4) ◽

pp. 636 ◽

Cited By ~ 1

Author(s):

Karl H. Pang ◽

Aidan P. Noon

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Radical Cystectomy ◽

Feasibility Study ◽

Invasive Bladder Cancer ◽

Bcg Immunotherapy ◽

Intravesical Bcg ◽

Muscle Invasive ◽

Randomised Controlled

Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy

World Journal of Urology ◽

10.1007/s00345-011-0681-4 ◽

2011 ◽

Vol 29 (4) ◽

pp. 415-422 ◽

Cited By ~ 16

Author(s):

D. R. Yates ◽

M. Rouprêt

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Invasive Bladder Cancer ◽

Bcg Therapy ◽

Intravesical Bcg ◽

Muscle Invasive ◽

Contemporary Management ◽

Intravesical Bcg Therapy

Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer

World Journal of Urology ◽

10.1007/s00345-018-2375-7 ◽

2018 ◽

Vol 37 (1) ◽

pp. 155-163 ◽

Cited By ~ 4

Author(s):

Tomas Thiel ◽

Charlotta Ryk ◽

Lotta Renström-Koskela ◽

Gunnar Steineck ◽

Martin C. Schumacher ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Invasive Bladder Cancer ◽

Intravesical Bcg ◽

Covid-19 Threat in Patients with High-Risk Non-Muscle Invasive Bladder Cancer Receiving Intravesical BCG Therapy

10.22541/au.159915064.47211533 ◽

2020 ◽

Author(s):

Serkan Akan ◽

Caner Ediz ◽

Yunus Emre Kizilkan ◽

Adem Alcin ◽

Hasan Huseyin Tavukcu ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Invasive Bladder Cancer ◽

Bcg Therapy ◽

Intravesical Bcg ◽

Muscle Invasive ◽

Intravesical Bcg Therapy